Nexalin Technology, Inc. Common Stock (NXL) is a publicly traded Healthcare sector company. As of September 20, 2026, NXL trades at $5.02 with a market cap of $4.06M and a P/E ratio of -10.46. NXL moved +0.00% today. Year to date, NXL is -70.73%; over the trailing twelve months it is -79.31%. Its 52-week range spans $4.51 to $116.10. Rallies surfaces NXL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $5.02 |
| Market Cap | $4.06M |
| P/E Ratio | -10.46 |
| EPS | $-0.48 |
| Dividend Yield | 0.31% |
| 52-Week High | $116.10 |
| 52-Week Low | $4.51 |
| Volume | 14.84K |
| Avg Volume | 0 |
| Revenue (TTM) | $217.16K |
| Net Income | $-8.99M |
| Gross Margin | 86.16% |
NXL analyst coverage data. Average price target: $0.00.